S 3812 Re-checks Congress.gov for new actions and updates the bill's status, and fills in any sponsors, committees, or related bills that are missing. It does not re-pull sponsors/cosponsors/committees/related — those rarely change — and it skips all work if nothing has changed upstream, so it's cheap to click.
To require the Secretary of Labor to issue guidance and regulations regarding opioid overdose reversal medication and employee training.
Summary
This bill requires the Secretary of Labor to issue non-mandatory guidance for private employers on acquiring opioid overdose reversal medication and training employees on its use annually. The bill also requires the Secretary of Labor to issue mandatory regulations requiring all Federal agencies to acquire and maintain opioid overdose reversal medication and provide annual employee training on its usage. The guidance for private employers and the regulations for Federal agencies must be developed within 270 days of enactment.
AI-generated plain-language summary of the bill text — neutral, and may be imperfect. See the full text below for the exact wording.
Sponsor (1)
- Sen. Merkley, Jeff [D-OR] (D-OR)
5 cosponsors
- Sen. Alsobrooks, Angela D. [D-MD] (D-MD)
- Sen. Heinrich, Martin [D-NM] (D-NM)
- Sen. Murkowski, Lisa [R-AK] (R-AK)
- Sen. Schiff, Adam B. [D-CA] (D-CA)
- Sen. Wyden, Ron [D-OR] (D-OR)
Actions (3)
- Mar 19, 2026 Committee on Health, Education, Labor, and Pensions. Hearings held. · senate
- Feb 10, 2026 Read twice and referred to the Committee on Health, Education, Labor, and Pensions. · senate
- Feb 10, 2026 Introduced in Senate
Similar bills (6)
Bills with similar text or summary — includes reintroductions across Congresses. Ranked by semantic similarity of the bill text (computed locally); a neutral discovery aid, not a claim the bills are duplicates.
Committee action
What happened to this bill in committee — the meetings where it was considered and every recorded vote taken on it.
Meetings where this bill was on the agenda
Full text
IN THE SENATE OF THE UNITED STATES
February 10, 2026
Mr. Merkley (for himself, Ms. Murkowski, Mr. Heinrich, Mr. Schiff, and Mr. Wyden) introduced the following bill; which was read twice and referred to the Committee on Health, Education, Labor, and Pensions
A BILL
To require the Secretary of Labor to issue guidance and regulations regarding opioid overdose reversal medication and employee training.
Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the “Workplace Overdose Reversal Kits to Save Lives Act” or the “WORK to Save Lives Act”.
SEC. 2. NON-MANDATORY GUIDANCE FOR EMPLOYERS CONCERNING OPIOID OVERDOSE REVERSAL MEDICATION.
(a) In General.—Not later than 270 days after the date of enactment of this Act, the Secretary of Labor, acting through the Occupational Safety and Health Administration, shall issue nonmandatory guidance to employers on—
(1) acquiring and maintaining opioid overdose reversal medication; and
(2) training employees on an annual basis on the usage of such medication.
(b) Employer Defined.—In this section, the term “employer” has the meaning given such term in section 3 of the Occupational Safety and Health Act of 1970 (29 U.S.C. 652), except that such term does not include the United States Postal Service.
SEC. 3. MANDATORY REGULATIONS FOR FEDERAL AGENCIES CONCERNING OPIOID OVERDOSE REVERSAL MEDICATION.
(a) In General.—Not later than 270 days after the date of enactment of this Act, the Secretary of Labor, acting through the Occupational Safety and Health Administration, shall issue regulations to require each Federal agency to—
(1) acquire and maintain opioid overdose reversal medication; and
(2) train employees on an annual basis on the usage of such medication.
(b) Federal Agency Defined.—In this section, the term “Federal agency” means any agency or instrumentality of the Federal Government, including the Veterans Health Administration, notwithstanding section 7425(b) of title 38, United States Code. <all>
Comments